KR100911357B1 - PROCESS OF PREPARING alpha;-KETO CYANOPHOSPHORANES FROM CARBONYL COMPOUNDS - Google Patents

PROCESS OF PREPARING alpha;-KETO CYANOPHOSPHORANES FROM CARBONYL COMPOUNDS Download PDF

Info

Publication number
KR100911357B1
KR100911357B1 KR1020080030201A KR20080030201A KR100911357B1 KR 100911357 B1 KR100911357 B1 KR 100911357B1 KR 1020080030201 A KR1020080030201 A KR 1020080030201A KR 20080030201 A KR20080030201 A KR 20080030201A KR 100911357 B1 KR100911357 B1 KR 100911357B1
Authority
KR
South Korea
Prior art keywords
compound
formula
group
keto
oxo
Prior art date
Application number
KR1020080030201A
Other languages
Korean (ko)
Inventor
이기승
Original Assignee
우석대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 우석대학교 산학협력단 filed Critical 우석대학교 산학협력단
Priority to KR1020080030201A priority Critical patent/KR100911357B1/en
Application granted granted Critical
Publication of KR100911357B1 publication Critical patent/KR100911357B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • C07F9/5022Aromatic phosphines (P-C aromatic linkage)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A method for producing an alpha-keto cyanophosphorane which is a core intermediate for making alpha-keto acid, imide, ester compound using a carbonyl compound is provided to reduce the production price and improve the yield of alpha-keto cyanophosphorane compound. A method for producing a beta,gamma-saturation alpha-keto cyanophosphorane compound of the chemical formula IV comprises: a step of performing Horner-Wadsworth-Emmons olefination of diethyl[3-cyano-2-oxo-3-(triphenylphosphoranyliden)propyl]phosphonate with a carbonyl compound of the chemical formula II; and a step of performing catalyst hydrogenation of beta,gamma-unsaturation alpha-keto cyanophosphorane compound.

Description

카르보닐 화합물로부터 α-케토 시아노포스포레인의 제조방법 {Process of preparing α-keto cyanophosphoranes from carbonyl compounds}Process for preparing α-keto cyanophosphoranes from carbonyl compounds

본 발명은 생리활성이 있는 알파-케토 산, 아미드 및 에스테르 화합물을 제조하기 위한 핵심 중간체인 α-케토 시아노포스포레인의 제조방법에 관한 것이다. 보다 구체적으로, 본 발명은 상업적으로 염가에 쉽게 구입할 수 있는 카르보닐 화합물을 출발물질로 사용하여 다양한 α-케토 시아노포스포레인 화합물을 용이하게 고수율로 제조하는 방법에 관한 것이다. The present invention relates to a method for preparing α-keto cyanophosphorane, which is a key intermediate for preparing physiologically active alpha-keto acids, amides and ester compounds. More specifically, the present invention relates to a method for easily preparing a variety of α-keto cyanophosphorane compounds in high yield using a commercially available carbonyl compound which is readily available at low cost.

α-케토 산, 아미드 및 에스테르 (α-keto acid, amide and esters) 구조 단위는 생리활성이 있는 많은 천연물질에서 발견되고 있으며, 또한 약리작용과 관련하여 합성 펩티드 화합물에도 도입되고 있는 전자결핍성 작용기로서 유기화학 및 약학분야에서 많은 관심을 끌고 있다 [참고문헌: Otto, H. H.; Schirmeister, T. Chem. Rev . 1997, 97, 133; Babine, R. E.; Bender, S. L. Chem . Rev . 1997, 97, 1359; Cooper, A. J. E.; Ginos, J. Z.; Meister, A. Chem . Rev . 1983, 83, 321]. 따라서, α-케토 산, 아미드 및 에스테르 작용기를 합성하는 다수의 방법들이 문헌에 보고되어 있는데, 특히 미국 특허 제 5,834,588호에는 하기 반응식 1에서와 같이, (트리페닐포스포라닐리덴)아세토니트닐 (1)을 이용하여 α-케토 산, 아미드 및 에스테르 화합물 (6)을 합성하는 방법이 보고되어 있다 [참고문헌: Wasserman, H. H.; Ho, W.-B. J. Org . Chem . 1994, 59, 4364-4366]. α-keto acid, amide and esters structural units are found in many biologically active natural substances and are also introduced into the synthetic peptide compounds in relation to pharmacological action. Has attracted a lot of attention in organic chemistry and pharmacy. [References: Otto, HH; Schirmeister, T. Chem. Rev. 1997 , 97 , 133; Babine, RE; Bender, SL Chem . Rev. 1997 , 97 , 1359; Cooper, AJE; Ginos, JZ; Meister, A. Chem . Rev. 1983 , 83 , 321]. Thus, a number of methods for synthesizing α-keto acids, amides and ester functionalities have been reported in the literature, and in particular US Pat. No. 5,834,588 discloses (triphenylphosphoranylidene) acetonitrile ( A method for synthesizing α-keto acid, amide and ester compound ( 6 ) using 1 ) has been reported [Wasserman, HH; Ho, W.-B. J. Org . Chem . 1994 , 59 , 4364-4366.

[반응식 1] Scheme 1

Figure 112008023590483-pat00001
Figure 112008023590483-pat00001

상기 방법은 반응조건의 온화함, 반응과정의 수렴성 및 반응의 폭넓은 적용범위 등의 관점에서 판단할 때 α-케토 산, 아미드 및 에스테르 화합물을 합성하는 매우 우수한 방법으로서 생리활성을 갖는 다양한 화합물의 제조에 광범위하게 이용되어 왔다 [참고문헌: Wasserman, H. H.; Chen, J.-H.; Xia, M. J. Am . Chem . Soc . 1999, 121, 1401; Wasserman, H. H.; Zhang, R. Tetrahedron 2002, 58, 6277; Lee, K. Bull . Korean Chem . Soc . 2002, 23, 351; Price, W. S.; Fletcher, S.; Jorgensen, M. R.; Miller, A. D. Synlett 2006, 1933]. 그러나, 상기 방법은 반응과정에서 핵심 중간체인 α-케토 시아노포스포레인 (α-keto cyanophosphoranes, 3)의 합성에 출발물질로 카르복실산 혹은 카르복실산 염화물 (2)을 반드시 필요로 하는데, 이들 화합물들은 종종 구하기 어렵거나 합성에 강력한 시약을 필요로 하며 또한 쉽게 가수분해되는 등의 성질을 가지고 있어서 다양한 α-케토 시아노포스포레인 (3)을 합성하는데 문제점을 가지고 있으며 따라서, 다양한 α-케토산, 아미드 및 에스테르 화합물의 상업적 제조법으로 이용하는데 한계점이 있다. The method is a very excellent method for synthesizing α-keto acid, amide and ester compounds in view of the mildness of the reaction conditions, the convergence of the reaction process, and the wide range of application of the reaction. Has been widely used in [Ref .: Wasserman, HH; Chen, J.-H .; Xia, M. J. Am . Chem . Soc . 1999 , 121 , 1401; Wasserman, HH; Zhang, R. Tetrahedron 2002 , 58 , 6277; Lee, K. Bull . Korean Chem . Soc . 2002 , 23 , 351; Price, WS; Fletcher, S .; Jorgensen, MR; Miller, AD Synlett 2006 , 1933. However, the method to a key intermediate, α- cyano-keto-established Lane Spokane (α-keto cyanophosphoranes, 3) as a starting material for the synthesis of the carboxylic acid or the required acid chloride (2) in the course of the reaction, these Compounds often have difficulties in synthesizing various α-keto cyanophosphorane ( 3 ) because they are often difficult to obtain or require strong reagents for synthesis, and are easily hydrolyzed, and therefore, various α-keto acids There are limitations to the use in the commercial preparation of, amide and ester compounds.

이에, 본 발명자들은 상기한 문제점을 극복하기 위하여 예의 연구 검토한 결과, 상업적으로 염가에 쉽게 구입할 수 있는 카르보닐 화합물로부터 다양한 α-케토 시아노포스포레인을 용이하게 고수율로 제조할 수 있음을 발견하고 본 발명을 완성하게 되었다.Accordingly, the present inventors have studied diligently to overcome the above problems, and found that various α-keto cyanophosphorane can be easily produced in high yield from a carbonyl compound which can be easily purchased at low cost. This invention was completed.

따라서, 본 발명의 목적은 카르보닐 화합물을 출발물질로 사용하여 다양한 α-케토 시아노포스포레인을 제조하는 방법을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a method for preparing various α-keto cyanophosphorines using a carbonyl compound as a starting material.

본 발명을 설명하기에 앞서 명세서 및 특허청구범위 전반에 걸쳐 사용되는 다음의 몇 가지 중요한 용어부터 정의하기로 한다. Before describing the present invention, the following several important terms used throughout the specification and claims are defined.

본 명세서에서 사용되는 C1-C15의 알킬기는 탄소수 1 내지 15개로 구성된 직 쇄형 또는 분지형 탄화수소를 의미하며, 예를 들어 메틸, 에틸, 프로필, 부틸, 펜틸, 헥실 등이 포함되나 이에 한정되는 것은 아니다.As used herein, an alkyl group of C 1 -C 15 refers to a straight or branched hydrocarbon having 1 to 15 carbon atoms, and includes, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, and the like. It is not.

본 명세서에서 사용되는 C3-C10의 사이클로알킬기는 탄소수 3 내지 10개로 구성된 고리형 탄화수소를 의미하며, 예를 들어 사이클로프로필, 사이클로부틸, 사이클로펜틸, 사이클로헥실 등이 포함되나 이에 한정되는 것은 아니다. As used herein, a C 3 -C 10 cycloalkyl group means a cyclic hydrocarbon composed of 3 to 10 carbon atoms, and examples include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and the like. .

본 명세서에서 사용되는 아릴기는 아로메틱기와 헤테로아로메틱기 및 그들의 부분적으로 환원된 유도체를 모두 포함한다. 상기 아로메틱기는 5 내지 15각형으로 이루어진 단순 또는 융합 고리형이며, 헤테로아로메틱기는 산소, 황 또는 질소를 하나 이상 포함하는 아로메틱기를 의미한다. 대표적인 아릴기의 예로는 페닐, 나프틸, 피디릴, 인돌릴(indolyl), 퀴놀리닐(quinolinyl), 이미다졸리닐(imidazolinyl), 옥사졸릴(oxazolyl), 티아졸릴(thiazolyl), 테트라히드로나프틸 등이 있으나 이에 한정되는 것은 아니다. As used herein, the aryl group includes both aromatic groups and heteroaromatic groups and their partially reduced derivatives. The aromatic group is a simple or fused cyclic consisting of 5 to 15 pentagons, heteroaromatic group refers to an aromatic group containing one or more oxygen, sulfur or nitrogen. Examples of representative aryl groups are phenyl, naphthyl, pyridyl, indolyl, quinolinyl, imidazolinyl, oxazolyl, thiazolyl, thiazolyl, tetrahydronaph And the like, but are not limited thereto.

상기 C1-C15의 알킬기, C3-C10의 사이클로알킬기 및 아릴기는 한 개 또는 그 이상의 수소가 C1-C5의 알킬기, C2-C6의 알케닐기, C2-C6의 알키닐기, C3-C10의 시클로알킬기, C1-C5의 알콕시기, C1-C5의 티오알콕시기, 아릴기, 아실기, 히드록시, 티오(thio), 할로, 아미노, 알콕시카보닐, 카복시, 카바모일, 시아노, 니트로 등으로 치환될 수 있다.The C 1 -C 15 alkyl group, C 3 -C 10 cycloalkyl group and aryl group is one or more hydrogen is C 1 -C 5 alkyl group, C 2 -C 6 alkenyl group, C 2 -C 6 Alkynyl group, C 3 -C 10 cycloalkyl group, C 1 -C 5 alkoxy group, C 1 -C 5 thioalkoxy group, aryl group, acyl group, hydroxy, thio, halo, amino, alkoxy Carbonyl, carboxy, carbamoyl, cyano, nitro and the like.

본 명세서에서 사용되는 카르보닐 화합물은 알데히드 및 케톤 화합물을 의미한다.Carbonyl compound as used herein refers to aldehyde and ketone compounds.

이하, 본 발명을 보다 구체적으로 설명하고자 한다. 본 발명은 카르보닐 화합물을 출발물질로 사용하여 α-케토 시아노포스포레인을 제조하는 방법에 관한 것이다. 본 발명의 제조방법은 Hereinafter, the present invention will be described in more detail. The present invention relates to a method for preparing α-keto cyanophosphorane using a carbonyl compound as a starting material. The manufacturing method of the present invention

(i) 하기 화학식 I의 디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트를 하기 화학식 II의 카르보닐 화합물과 호르너-워스워스-에몬스 (Horner-Wadsworth-Emmons) 올레핀화 반응시켜 하기 화학식 III의 β,γ-불포화 α-케토 시아노포스포레인 화합물을 수득하는 단계; 및(i) diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate of formula (I) with Hornyl-Worthworth-Emons (Horner-Wadsworth-Emmons) olefination to obtain a β, γ-unsaturated α-keto cyanophosphorane compound of formula III; And

(ii) 임의로, 하기 화학식 III의 β,γ-불포화 α-케토 시아노포스포레인 화합물을 촉매 수소화 반응을 시켜 하기 화학식 IV의 β,γ-포화 α-케토 시아노포스포레인 화합물을 수득하는 단계를 포함한다. (ii) optionally subjecting the β, γ-unsaturated α-keto cyanophosphorane compound of formula III to catalytic hydrogenation to obtain a β, γ-saturated α-keto cyanophosphorane compound of formula IV Include.

[화학식 I][Formula I]

Figure 112008023590483-pat00002
Figure 112008023590483-pat00002

[화학식 II][Formula II]

Figure 112008023590483-pat00003
Figure 112008023590483-pat00003

[화학식 III][Formula III]

Figure 112008023590483-pat00004
Figure 112008023590483-pat00004

[화학식 IV][Formula IV]

Figure 112008023590483-pat00005
Figure 112008023590483-pat00005

상기 식에서, R1 및 R2는 각각 독립적으로 수소, C1-C15의 알킬기, C3-C10의 사이클로알킬기 또는 아릴기이다.In the above formula, R 1 and R 2 are each independently hydrogen, an alkyl group of C 1 -C 15 , a cycloalkyl group of C 3 -C 10 , or an aryl group.

상기 C1-C15의 알킬기는 바람직하게는 페닐기 또는 t-부틸옥시카보닐 (BOC) 등에 의해 보호되거나 비보호된 아미노기에 의해 치환될 수 있다. 상기 C1-C15의 알킬기의 예로는 메틸, 에틸, 프로필, 부틸, 펜틸, 헥실, 헵틸, 옥틸, 벤질, 2-페닐에틸, 아미노메틸, t-부틸옥시카보닐아미노메틸 등이 있으나 이에 한정되는 것은 아니다. The C 1 -C 15 alkyl group may be preferably substituted with an amino group protected or unprotected by a phenyl group or t-butyloxycarbonyl (BOC) or the like. Examples of the C 1 -C 15 alkyl group include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, benzyl, 2-phenylethyl, aminomethyl, t-butyloxycarbonylaminomethyl, and the like. It doesn't happen.

한편, 상기 아릴기는 하나 이상의 C1-C5의 알킬기에 의해 치환될 수 있다. 상기 아릴기의 예로는 페닐, 2-메틸페닐, 3-메틸페닐, 4-메틸페닐, 2,4-디메틸페닐, 2,6-디메틸페닐 등이 있으나 이에 한정되는 것은 아니다. On the other hand, the aryl group may be substituted by one or more C 1 -C 5 alkyl group. Examples of the aryl group include, but are not limited to, phenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 2,4-dimethylphenyl, 2,6-dimethylphenyl, and the like.

이하, 본 발명의 제조방법을 하기 반응식 2를 참조로 보다 상세히 설명하고 자 한다. 하기 반응식 2에 기재된 방법은 대표적으로 사용된 방법을 예시한 것일 뿐 단위조작의 순서, 반응시약, 반응조건 등은 경우에 따라 변경될 수 있다.Hereinafter, the preparation method of the present invention will be described in more detail with reference to Scheme 2 below. The method described in Scheme 2 below merely illustrates the method used as a representative, the order of the unit operation, the reaction reagent, the reaction conditions and the like may be changed in some cases.

[반응식 2]Scheme 2

Figure 112008023590483-pat00006
Figure 112008023590483-pat00006

β,γ-불포화 α-케토 시아노포스포레인 화합물 (9)은 디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트 (7)를 카르보닐 화합물 (8)과 호르너-워스워스-에몬스 올레핀화 반응을 시켜서 제조한다 (단계 (i)). 구체적으로, 새로운 호르너-워스워스-에몬스 시약 (7)을 먼저 염기로 처리한 후 카르보닐 화합물 (8)과 반응시키면 축합반응이 일어나서 β,γ-불포화 α-케토 시아노포스포레인 화합물 (9)이 우수한 수율로 얻어진다. 이 때 사용되는 대표적인 염기로는 수소화나트륨 (NaH), 수산화리튬 (LiOH), 1,8-디아자비시클로[5.4.0]운데크-7-엔 (1,8-Diazabicyclo[5.4.0]undec-7-ene: DBU) 등이 있으나 이에 한정되는 것이 아니다. β, γ-unsaturated α-keto cyanophosphorane compound ( 9 ) carbonyl diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate ( 7 ) Prepared by subjecting compound ( 8 ) to a Horner-Worthworth-Emonth olefination reaction (step (i)). Specifically, when a new Horner-Worthworth-Emons reagent ( 7 ) is first treated with a base and then reacted with a carbonyl compound ( 8 ), a condensation reaction takes place, resulting in a β, γ-unsaturated α-keto cyanophosphorane compound ( 9 ) Is obtained with excellent yield. Representative bases used here include sodium hydride (NaH), lithium hydroxide (LiOH), 1,8-diazabicyclo [5.4.0] undec-7-ene (1,8-Diazabicyclo [5.4.0] undec -7-ene: DBU), but is not limited thereto.

β,γ-포화 α-케토 시아노포스포레인 화합물 (10)은 β,γ-불포화 α-케토 시아노포스포레인 화합물 (9)을 촉매 수소화 반응을 시켜서 제조한다 (단계 (ii)). 수소화 반응 과정에서 백금, 니켈, 팔라듐 등의 촉매가 사용 가능하지만, 가장 바람직하게는 팔라듐 촉매 (Pd-C) 속에서 1 기압의 수소 기체를 이용하여 수행하는 것이 바람직하다. β, γ-saturated α-keto cyanophosphorane compound ( 10 ) is prepared by catalytic hydrogenation of β, γ-unsaturated α-keto cyanophosphorane compound ( 9 ) (step (ii)). Catalysts such as platinum, nickel and palladium may be used in the hydrogenation process, but most preferably, it is carried out using a hydrogen gas of 1 atm in a palladium catalyst (Pd-C).

상기 디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트 (7)는 하기 반응식 3에 제시된 바와 같이, (트리페닐포스포라닐리덴)아세토니트닐 (1)을 염화아세트산 염화물 (11)과 반응시켜 4-클로로-3-옥소-2-(트리페닐포스포라닐리덴)부탄니트릴 (12)을 수득한 다음, 이를 다시 트리에틸 포스파이트와 반응시켜 제조할 수 있다. The diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate ( 7 ) is (triphenylphosphoranylidene) acetonitrile, as shown in Scheme 3 below. Neyl ( 1 ) is reacted with acetic acid chloride ( 11 ) to give 4-chloro-3-oxo-2- (triphenylphosphoranylidene) butannitrile ( 12 ), which is then reacted with triethyl phosphite Can be prepared.

[반응식 3]Scheme 3

Figure 112008023590483-pat00007
Figure 112008023590483-pat00007

본 명세서에서 사용되는 α-케토 시아노포스포레인 화합물은 상기 화학식 III의 β,γ-불포화 α-케토 시아노포스포레인 화합물과 상기 화학식 IV의 β,γ-포화 α-케토 시아노포스포레인 화합물을 모두 포함하며, 상기 반응식 1에 제시된 바와 같이 산화 반응시킨 후 물, 아민 및 알코올과 같은 친핵성 화합물과 반응시켜 α-케토 산, 아미드 및 에스테르 화합물을 제조하는데 사용될 수 있다.As used herein, the α-keto cyanophosphorane compound may be a β, γ-unsaturated α-keto cyanophosphorane compound of Formula III and a β, γ-saturated α-keto cyanophosphorane compound of Formula IV. All are included and can be used to prepare α-keto acid, amide and ester compounds by oxidative reaction as shown in Scheme 1 and then reacted with nucleophilic compounds such as water, amine and alcohol.

본 발명의 제조방법에 따르면, 다양한 알파-케토 산, 아미드 및 에스테르 화합물의 제조 과정에서 핵심 중간체인 다양한 α-케토 시아노포스포레인 화합물을 상업적으로 염가에 쉽게 구입할 수 있는 카르보닐 화합물을 출발물질로 사용하여 용이하게 고수율로 제조할 수 있다. According to the preparation method of the present invention, as a starting material, a carbonyl compound which can be easily and cheaply commercially purchased various α-keto cyanophosphorane compounds which are key intermediates in the preparation of various alpha-keto acid, amide and ester compounds It can be easily produced in high yield .

이하, 실시예에 의해 본 발명을 보다 구체적으로 설명하고자 한다. 이들 실시예는 오직 본 발명을 설명하기 위한 것으로 본 발명의 범위가 이들 실시예에 국한되지 않는다는 것은 당업자에게 있어서 자명하다.Hereinafter, the present invention will be described in more detail with reference to Examples. It is apparent to those skilled in the art that these examples are only for illustrating the present invention, and the scope of the present invention is not limited to these examples.

제조예Production Example 1: 4- 1: 4- 클로로Chloro -3-옥소-2-(-3-oxo-2- ( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 부탄니트릴Butanenitrile (4- (4- ChloroChloro -3--3- oxooxo -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) butanenitrilebutanenitrile ))

(트리페닐포스포라닐리덴)아세토니트릴 (2.59 g, 8.60 mmol)을 함유한 무수 염화 메틸렌 (30 mL) 용액을 0 oC로 냉각시키고, N,O-비스(트리메틸실릴)아세트아미드 (2.55 mL, 1.2 당량)를 가한 후, 아르곤 기체 속에서 30분 동안 교반시킨 다음, 염화아세트산 염화물 (0.69 mL, 1.0 당량)를 가하고 0 oC에서 1시간 동안 교반시킨 후 상온에서 10시간 동안 교반시켰다. 이어서 반응 용액에 물 (20 mL)을 가하여 반응을 정지시키고, 분액 깔대기로 두 층을 분리한 후 수용액 층을 염화 메틸렌 (10 mL)으로 2회 추출하였다. 분리한 염화 메틸렌층을 전부 합한 후 무수 마그네슘 설페이트 (5 g)을 가하여 수분을 제거하고, 여과한 후 감압 하에서 용매를 제거하였다. 얻어진 잔류물을 크로마토그래피 (실리카겔 컬럼; 20 cm x 2 cm, Merck 70- 230, 용매는 염화 메틸렌 : 에틸아세테이트 = 20 : 1)를 사용하여 분리하여 순수한 화합물인 4-클로로-3-옥소-2-(트리페닐포스포라닐리덴)부탄니트릴을 수득하였다. 수율: 2.66 g (82%).Anhydrous methylene chloride (30 mL) solution containing (triphenylphosphoranylidene) acetonitrile (2.59 g, 8.60 mmol) was cooled to 0 ° C. and N , O -bis (trimethylsilyl) acetamide (2.55 mL , 1.2 equivalents), and stirred in argon gas for 30 minutes, followed by addition of acetic acid chloride (0.69 mL, 1.0 equivalents), stirred at 0 ° C. for 1 hour, and then stirred at room temperature for 10 hours. Water (20 mL) was then added to the reaction solution to stop the reaction. The two layers were separated with a separatory funnel, and the aqueous layer was extracted twice with methylene chloride (10 mL). After all the separated methylene chloride layers were combined, anhydrous magnesium sulfate (5 g) was added to remove water, filtered and the solvent was removed under reduced pressure. The resulting residue was separated using chromatography (silica gel column; 20 cm x 2 cm, Merck 70-230, solvent was methylene chloride: ethyl acetate = 20: 1) to give 4-chloro-3-oxo-2 as a pure compound. -(Triphenylphosphoranilidene) butanenitrile was obtained. Yield: 2.66 g (82%).

연한 갈색 고체; mp 185-187 oC; IR (KBr) 3064, 3027, 2956, 2180, 1594 cm-1; 1H NMR (CDCl3, 400 MHz) 4.44 (s, 2H), 7.49-7.72 (m, 15H).Light brown solid; mp 185-187 o C; IR (KBr) 3064, 3027, 2956, 2180, 1594 cm -1 ; 1 H NMR (CDCl 3 , 400 MHz) 4.44 (s, 2 H), 7.49-7.72 (m, 15 H).

제조예Production Example 2:  2: 디에틸Diethyl [3- [3- 시아노Cyano -2-옥소-3-(-2-oxo-3- ( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )프로필])profile] 포스포네이트Phosphonates (( DiethylDiethyl [3- [3- cyanocyano -2--2- oxooxo -3-(-3- ( triphenylphosphoranylidenetriphenylphosphoranylidene )) propylpropyl ]] phosphonatephosphonate ))

상기 실시예 1에서 수득한 4-클로로-3-옥소-2-(트리페닐포스포라닐리덴)부탄니트릴 (2.20 g, 5.83 mmol)에 트리에틸 포스파이트 (10 mL)를 가하고, 아르곤 기체 속에서 110 oC로 24시간 동안 가열하고 냉각한 다음 트리에틸 포스파이트를 진공 증류하여 제거하였다. 고체 잔류물을 에틸 아세테이트 (60 mL)를 사용하여 재결정하여 결정 형태의 표제 화합물 (2.50 g)을 얻고, 이어서 여과액에서 용매를 제거하고 재결정 과정을 반복하여 여분의 생성물 (0.15 g)을 더 얻었다. 총수율: 2.65 g (95%). Triethyl phosphite (10 mL) was added to 4-chloro-3-oxo-2- (triphenylphosphoranylidene) butannitrile (2.20 g, 5.83 mmol) obtained in Example 1, and in argon gas Heated to 110 ° C. for 24 hours, cooled and triethyl phosphite was removed by vacuum distillation. The solid residue was recrystallized with ethyl acetate (60 mL) to give the title compound (2.50 g) in crystalline form, followed by removal of the solvent from the filtrate and repeating the recrystallization process to give extra product (0.15 g). . Total yield: 2.65 g (95%).

흰색 고체; mp 180.0-182.0 oC; IR (KBr) 3057, 2982, 2916, 2173, 1586 cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.31 (t, 6H, J = 7.1 Hz), 3.37 (d, 2H, J H-P = 22.0 Hz), 4.16 (m, 4H), 7.49-7.71 (m, 15H).; 13C NMR (CDCl3, 100 MHz) δ 16.3 (d, J C -P = 5.8 Hz), 38.4 (dd, J 1 ,C-P = 129.9 Hz, J 2,C-P = 7.4 Hz), 51.0 (dd, J 1 ,C-P = 126.7 Hz, J 2,C-P = 5.0 Hz), 62.2 (d, J C -P = 5.8 Hz), 121.9 (d, J C -P = 15.7 Hz), 122.8 (d, J C -P = 93.5 Hz), 129.1 (d, J C -P = 13.2 Hz), 133.1 (d, J C -P = 3.3 Hz), 133.6 (d, J C -P = 10.8 Hz), 186.9 (dd, J 1 ,C-P = 6.6 Hz, J 2,C-P = 5.0 Hz); HRMS calcd for C26H27NO4P2 479.1415, found 479.1412; Anal. calcd for C26H27NO4P2: C, 65.13; H, 5.68; N, 2.92. found: C, 65.36; H, 5.67; N, 2.96.White solid; mp 180.0-182.0 o C; IR (KBr) 3057, 2982, 2916, 2173, 1586 cm −1 ; 1 H NMR (CDCl 3 , 400 MHz) δ 1.31 (t, 6H, J = 7.1 Hz), 3.37 (d, 2H, J HP = 22.0 Hz), 4.16 (m, 4H), 7.49-7.71 (m, 15H ) .; 13 C NMR (CDCl 3 , 100 MHz) δ 16.3 (d, J C -P = 5.8 Hz), 38.4 (dd, J 1 , CP = 129.9 Hz, J 2 , CP = 7.4 Hz), 51.0 (dd, J 1 , CP = 126.7 Hz, J 2 , CP = 5.0 Hz), 62.2 (d, J C -P = 5.8 Hz), 121.9 (d, J C -P = 15.7 Hz), 122.8 (d, J C -P = 93.5 Hz), 129.1 (d, J C -P = 13.2 Hz), 133.1 (d, J C -P = 3.3 Hz), 133.6 (d, J C -P = 10.8 Hz), 186.9 (dd, J 1 , CP = 6.6 Hz, J 2 , CP = 5.0 Hz); HRMS calcd for C 26 H 27 NO 4 P 2 479.1415, found 479.1412; Anal. calcd for C 26 H 27 NO 4 P 2 : C, 65.13; H, 5.68; N, 2.92. found: C, 65.36; H, 5.67; N, 2.96.

실시예Example 1: 3-옥소-5- 1: 3-oxo-5- 페닐Phenyl -2-(-2-( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 펜트Pent -4--4- 엔니트릴Ennitrile (3- (3- OxoOxo -5--5- phenylphenyl -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) pentpent -4--4- enenitrileenenitrile ))

디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트 (240.0 mg, 0.50 mmol)을 함유한 무수 테트라히드로푸란 (THF) (15 mL)에 NaH (26.1 mg, 60% in oil, 1.3 당량)을 가하고, 아르곤 기체 속에서 상온에서 20분, 0 ℃에서 20분 동안 교반하여 연한 황갈색 용액을 수득하였다. 이 용액에 벤즈알데히드 (50.8 mL, 1 당량)를 가하고 0 ℃에서 30분, 상온에서 1시간 동안 교반한 후, 물 (15 mL)을 가하여 반응을 정지시키고 생성물을 CH2Cl2 (20 mL)로 3회 추출하였다. 분리한 유기층을 전부 합하고 무수 마그네슘 설페이트 (5 g)을 가하여 수분을 제거한 다음 여과 후 농축하였다. 얻어진 잔류물을 크로마토그래피 (실리카겔 컬럼; 20 cm x 2 cm, Merck 70-230, 용매; 디클로로메탄 : 헥산 = 15 : 1)로 분리하여 201.0 mg (93 %)의 연노란색 고체인 표제 화합물을 수득하였다. NaH in anhydrous tetrahydrofuran (THF) (15 mL) containing diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate (240.0 mg, 0.50 mmol) (26.1 mg, 60% in oil, 1.3 equiv) was added and stirred in argon gas for 20 minutes at room temperature and 0 ° C. for 20 minutes to give a light tan solution. Benzaldehyde (50.8 mL, 1 equiv) was added to the solution, stirred at 0 ° C. for 30 minutes at room temperature for 1 hour, and then water (15 mL) was added to stop the reaction. The product was purified by CH 2 Cl 2 (20 mL). Extracted three times. All the separated organic layers were combined, anhydrous magnesium sulfate (5 g) was added to remove water, and then filtered and concentrated. The residue obtained is separated by chromatography (silica gel column; 20 cm × 2 cm, Merck 70-230, solvent; dichloromethane: hexane = 15: 1) to give 201.0 mg (93%) of the title compound as a pale yellow solid. It was.

mp 232.0-234.0 ℃; IR (KBr) 2172, 1636 cm-1; 1H NMR (CDCl3, 400 MHz) δ7.30-7.70 (m, 22H); 13C NMR (CDCl3, 100 MHz) δ 50.9 (d, J C -P = 128.3 Hz), 122.1 (d, J C -P = 15.7 Hz), 123.2 (d, J C -P = 93.5 Hz), 123.7 (d, J C -P = 9.1 Hz), 128.1, 128.6, 129.2 (d, J C -P = 12.4 Hz), 129.3, 133.1 (d, J C -P = 3.3 Hz), 133.6 (d, J C -P = 9.9 Hz), 135.4, 138.9 (d, J C -P = 1.7 Hz), 185.8 (d, J C -P = 3.3 Hz); HRMS calcd for C29H22NOP 431.1439, found 431.1430.mp 232.0-234.0 ° C .; IR (KBr) 2172, 1636 cm −1 ; 1 H NMR (CDCl 3 , 400 MHz) δ 7.30-7.70 (m, 22H); 13 C NMR (CDCl 3 , 100 MHz) δ 50.9 (d, J C -P = 128.3 Hz), 122.1 (d, J C -P = 15.7 Hz), 123.2 (d, J C -P = 93.5 Hz), 123.7 (d, J C -P = 9.1 Hz), 128.1, 128.6, 129.2 (d, J C -P = 12.4 Hz ), 129.3, 133.1 (d, J C -P = 3.3 Hz), 133.6 (d, J C -P = 9.9 Hz), 135.4, 138.9 (d, J C -P = 1.7 Hz), 185.8 (d, J C -P = 3.3 Hz); HRMS calcd for C 29 H 22 NOP 431.1439, found 431.1430.

실시예Example 2: 3-옥소-5- 2: 3-oxo-5- oo -- 톨릴Tolyl -2-(-2-( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 펜트Pent -4--4- 엔니트릴Ennitrile (3- (3- OxoOxo -5--5- oo -- tolyltolyl -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) pentpent -4--4- enenitrileenenitrile ))

디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트 (202.0 mg, 0.42 mmol)을 함유한 무수 THF (10 mL)에 NaH (21.9 mg, 60% in oil, 1.3 당량)을 가하고, 아르곤 기체 속에서 상온에서 20분, 0 ℃에서 20분 동안 교반하여 연한 황갈색 용액을 수득하였다. 이 용액에 o-톨루알데히드 (50.3 mL, 1 당량)를 가하고 0 ℃에서 30분, 상온에서 3시간 동안 교반한 후, 물 (10 mL)을 가하 여 반응을 정지시키고 생성물을 CH2Cl2 (15 mL)로 3회 추출하였다. 분리한 유기층을 전부 합하고 무수 마그네슘 설페이트 (5 g)을 가하여 수분을 제거한 다음 여과 후 농축하였다. 얻어진 잔류물을 크로마토그래피 (실리카겔 컬럼; 20 cm x 2 cm, Merck 70-230, 용매; 헥산 : 에틸 아세테이트 = 2 : 3)로 분리하여 176.7 mg (91 %)의 표제 화합물을 수득하였다. NaH (21.9 mg, 60 in anhydrous THF (10 mL) containing diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate (202.0 mg, 0.42 mmol) % in oil, 1.3 equivalents) was added and stirred in argon gas at room temperature for 20 minutes and at 0 ° C. for 20 minutes to give a light tan solution. To this solution was added o -tolualdehyde (50.3 mL, 1 equiv), stirred at 0 ° C. for 30 minutes at room temperature for 3 hours, and then water (10 mL) was added to stop the reaction and the product was CH 2 Cl 2 ( 15 mL). All the separated organic layers were combined, anhydrous magnesium sulfate (5 g) was added to remove water, and then filtered and concentrated. The residue obtained was separated by chromatography (silica gel column; 20 cm × 2 cm, Merck 70-230, solvent; hexanes: ethyl acetate = 2: 3) to give 176.7 mg (91%) of the title compound.

1H NMR (CDCl3, 400 MHz) δ 2.42 (s, 3H), 7.13-7.25 (m, 4H), 7.39 (d, 1H, J = 15.6 Hz), 7.52-7.75 (m, 15H), 7.92 (d, 1H, J = 15.6 Hz). 1 H NMR (CDCl 3 , 400 MHz) δ 2.42 (s, 3H), 7.13-7.25 (m, 4H), 7.39 (d, 1H, J = 15.6 Hz), 7.52-7.75 (m, 15H), 7.92 ( d, 1H, J = 15.6 Hz).

실시예Example 3: 5-(2,6- 3: 5- (2,6- 디메틸페닐Dimethylphenyl )-3-옥소-2-() -3-oxo-2- ( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 펜트Pent -4--4- 엔니트릴Ennitrile (5-(2,6- (5- (2,6- DimethylphenylDimethylphenyl )-3-) -3- oxooxo -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) pentpent -4--4- enenitrileenenitrile ))

디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트 (228.5 mg, 0.48 mmol)을 함유한 무수 THF (15 mL)에 NaH (28.6 mg, 60% in oil, 1.3 당량)을 가하고, 아르곤 기체 속에서 상온에서 20분, 0 ℃에서 20분 동안 교반하여 연한 황갈색 용액을 수득하였다. 이 용액에 2,6-디메틸벤즈알데히드 (64.0 mg, 1 당량)를 가하고 0 ℃에서 30분, 상온에서 22시간 동안 교반한 후, 물 (15 mL)을 가하여 반응을 정지시키고 생성물을 CH2Cl2 (20 mL)로 3회 추출하였다. 분리한 유기층을 전부 합하고 무수 마그네슘 설페이트 (5 g)을 가하여 수분을 제거한 다음 여과 후 농축하였다. 얻어진 잔류물을 크로마토그래피 (실리카겔 컬럼; 20 cm x 2 cm, Merck 70-230, 용매; CH2Cl2 : 에틸 아세테이트 = 20 : 1)로 분리하여 191.0 mg (87 %)의 표제 화합물을 수득하였다. NaH (28.6 mg, 60 in anhydrous THF (15 mL) containing diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate (228.5 mg, 0.48 mmol) % in oil, 1.3 equivalents) was added and stirred in argon gas at room temperature for 20 minutes and at 0 ° C. for 20 minutes to give a light tan solution. 2,6-dimethylbenzaldehyde (64.0 mg, 1 equiv) was added to the solution, the mixture was stirred at 0 ° C. for 30 minutes at room temperature for 22 hours, and then water (15 mL) was added to stop the reaction. The product was changed to CH 2 Cl 2. Extracted with 3 times (20 mL). All the separated organic layers were combined, anhydrous magnesium sulfate (5 g) was added to remove water, and then filtered and concentrated. The residue obtained was separated by chromatography (silica gel column; 20 cm x 2 cm, Merck 70-230, solvent; CH 2 Cl 2 : ethyl acetate = 20: 1) to give 191.0 mg (87%) of the title compound. .

1H NMR (CDCl3, 400 MHz) δ 2.38 (s. 6H), 7.02-7.13 (m, 4H), 7.52-7.75 (m, 16H). 1 H NMR (CDCl 3 , 400 MHz) δ 2.38 (s. 6H), 7.02-7.13 (m, 4H), 7.52-7.75 (m, 16H).

실시예Example 4: 3-옥소-7- 4: 3-oxo-7- 페닐Phenyl -2-(-2-( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 헵트Hept -4--4- 엔니트릴Ennitrile (3- (3- OxoOxo -7--7- phenylphenyl -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) hepthept -4--4- enenitrileenenitrile ))

디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트 (342.0 mg, 0.71 mmol)을 함유한 무수 THF (20 mL)에 NaH (37.2 mg, 60% in oil, 1.3 당량)을 가하고, 아르곤 기체 속에서 상온에서 20분, 0 ℃에서 20분 동안 교반하여 연한 황갈색 용액을 수득하였다. 이 용액에 3-페닐프로피온알데히드 (94.2 mL, 1 당량)를 가하고 0 ℃에서 30분, 상온에서 1시간 동안 교반한 후, 물 (15 mL)을 가하여 반응을 정지시키고 생성물을 CH2Cl2 (20 mL)로 3회 추출하였다. 분리한 유기층을 전부 합하고 무수 마그네슘 설페이트 (5 g)을 가하여 수분을 제거한 다음 여과 후 농축하였다. 얻어진 잔류물을 크로마토그래피 (실리카겔 컬럼; 20 cm x 2 cm, Merck 70-230, 용매; CH2Cl2 : 에틸 아세테이트 = 20 : 1)로 분리하여 292.2 mg (89 %)의 표제 화합물을 수득하였다. NaH (37.2 mg, 60 in anhydrous THF (20 mL) containing diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate (342.0 mg, 0.71 mmol) % in oil, 1.3 equivalents) was added and stirred in argon gas at room temperature for 20 minutes and at 0 ° C. for 20 minutes to give a light tan solution. 30 minutes at 0 ℃ was added phenyl propionaldehyde (94.2 mL, 1 eq.) 3 to the solution, and the mixture was stirred at room temperature for 1 hour, the reaction was stopped by addition of water (15 mL) the product CH 2 Cl 2 Extracted with 3 times (20 mL). All the separated organic layers were combined, anhydrous magnesium sulfate (5 g) was added to remove water, and then filtered and concentrated. The residue obtained was separated by chromatography (silica gel column; 20 cm x 2 cm, Merck 70-230, solvent; CH 2 Cl 2 : ethyl acetate = 20: 1) to give 292.2 mg (89%) of the title compound. .

1H NMR (CDCl3, 400 MHz) δ 2.50-2.60 (m, 2H), 2.78 (t, 2H, J = 7.8 Hz), 6.86 (d, 1H, J = 15.4 Hz), 7.00 (dt, 1H, J 1 = 15.4 Hz, J 1 = 6.7 Hz), 7.15-7.31 (m, 5H), 7.51-7.71 (m, 15H). 1 H NMR (CDCl 3 , 400 MHz) δ 2.50-2.60 (m, 2H), 2.78 (t, 2H, J = 7.8 Hz), 6.86 (d, 1H, J = 15.4 Hz), 7.00 (dt, 1H, J 1 = 15.4 Hz, J 1 = 6.7 Hz), 7.15-7.31 (m, 5H), 7.51-7.71 (m, 15H).

실시예Example 5: 3-옥소-2-( 5: 3-oxo-2- ( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 도데크Dodec -4--4- 엔니트릴Ennitrile (3- (3- OxoOxo -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) dodecdodec -4--4- enenitrileenenitrile ))

디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트 (202.8 mg, 0.42 mmol)을 함유한 무수 THF (10 mL)에 NaH (22.0 mg, 60% in oil, 1.3 당량)을 가하고, 아르곤 기체 속에서 상온에서 20분, 0 ℃에서 20분 동안 교반하여 연한 황갈색 용액을 수득하였다. 이 용액에 옥탄알 (66.0 mL, 1 당량)를 가하고 0 ℃에서 30분, 상온에서 1시간 동안 교반한 후, 물 (10 mL)을 가하여 반응을 정지시키고 생성물을 CH2Cl2 (15 mL)로 3회 추출하였다. 분리한 유기층을 전부 합하고 무수 마그네슘 설페이트 (5 g)을 가하여 수분을 제거한 다음 여과 후 농축하였다. 얻어진 잔류물을 크로마토그래피 (실리카겔 컬럼; 20 cm x 2 cm, Merck 70-230, 용매; 헥산 : 에틸 아세테이트 = 1 : 1)로 분리하여 168.9 mg (88 %)의 표제 화합물을 수득하였다. NaH (22.0 mg, 60 in anhydrous THF (10 mL) containing diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate (202.8 mg, 0.42 mmol) % in oil, 1.3 equivalents) was added and stirred in argon gas at room temperature for 20 minutes and at 0 ° C. for 20 minutes to give a light tan solution. 30 minutes at 0 ℃ octane was added to Al (66.0 mL, 1 eq.) To the solution, and the mixture was stirred at room temperature for 1 hour, the reaction was stopped by addition of water (10 mL) the product CH 2 Cl 2 Extracted with (15 mL) three times. All the separated organic layers were combined, anhydrous magnesium sulfate (5 g) was added to remove water, and then filtered and concentrated. The residue obtained was separated by chromatography (silica gel column; 20 cm × 2 cm, Merck 70-230, solvent; hexanes: ethyl acetate = 1: 1) to give 168.9 mg (88%) of the title compound.

1H NMR (CDCl3, 400 MHz) δ 0.88 (t, 3H, J = 6.8 Hz), 1.20-1.34 (m, 8H), 1.41-1.47 (m, 2H), 2.20 (br q, 2H, J = 7.3 Hz), 6.74 (dt, 1H, J 1 = 15.1 Hz, J 2 = 6.9 Hz), 6.81 (d, 1H, J = 15.1 Hz), 7.49-7.54 (m, 5H), 7.60-7.66 (m, 10H). 1 H NMR (CDCl 3 , 400 MHz) δ 0.88 (t, 3H, J = 6.8 Hz), 1.20-1.34 (m, 8H), 1.41-1.47 (m, 2H), 2.20 (br q, 2H, J = 7.3 Hz), 6.74 (dt, 1H, J 1 = 15.1 Hz, J 2 = 6.9 Hz), 6.81 (d, 1H, J = 15.1 Hz), 7.49-7.54 (m, 5H), 7.60-7.66 (m, 10H).

실시예Example 6: [5- 6: [5- 시아노Cyano -4-옥소-5-(-4-oxo-5- ( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 펜트Pent -2-엔일]-2-yen] 카바믹Carbamic  mountain tt -부틸 에스테르 ([5--Butyl ester ([5- CyanoCyano -4--4- oxooxo -5-(-5- ( triphenylphosphoranylidenetriphenylphosphoranylidene )) pentpent -2--2- enylenyl ]] carbamiccarbamic acidacid tt -butyl -butyl esterester ))

디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트 (183.0 mg, 0.38 mmol)을 함유한 무수 THF (10 mL)에 NaH (19.8 mg, 60% in oil, 1.3 당량)을 가하고, 아르곤 기체 속에서 상온에서 20분, 0 ℃에서 20분 동안 교반하여 연한 황갈색 용액을 수득하였다. 이 용액에 N-BOC-2-아미노아세트알데히드 (64.0 mg, 1 당량)를 가하고 0 ℃에서 30분, 상온에서 1시간 동안 교반한 후, 물 (10 mL)을 가하여 반응을 정지시키고 생성물을 CH2Cl2 (15 mL)로 3회 추출하였다. 분리한 유기층을 전부 합하고 무수 마그네슘 설페이트 (5 g)을 가하여 수분을 제거한 다음 여과 후 농축하였다. 얻어진 잔류물을 크로마토그래피 (실리카겔 컬럼; 20 cm x 2 cm, Merck 70-230, 용매; 헥산 : 에틸 아세테이트 = 1 : 4)로 분리하여 164.6 mg (89 %)의 표제 화합물을 수득하였다. NaH (19.8 mg, 60 in anhydrous THF (10 mL) containing diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate (183.0 mg, 0.38 mmol) % in oil, 1.3 equivalents) was added and stirred in argon gas at room temperature for 20 minutes and at 0 ° C. for 20 minutes to give a light tan solution. N- BOC-2-aminoacetaldehyde (64.0 mg, 1 equiv) was added to the solution, stirred at 0 ° C. for 30 minutes at room temperature for 1 hour, and then water (10 mL) was added to stop the reaction. 2 Cl 2 Extracted with (15 mL) three times. All the separated organic layers were combined, anhydrous magnesium sulfate (5 g) was added to remove water, and then filtered and concentrated. The residue obtained was separated by chromatography (silica gel column; 20 cm x 2 cm, Merck 70-230, solvent; hexanes: ethyl acetate = 1: 4) to give 164.6 mg (89%) of the title compound.

1H NMR (CDCl3, 400 MHz) δ 1.44 (s, 9H), 3.90 (br s, 2H), 4.81 (br s, 1H), 6.68 (d, 1H, J = 15.4 Hz), 6.89 (d, 1H, J = 15.4 Hz), 7.45-7.70 (m, 15H). 1 H NMR (CDCl 3 , 400 MHz) δ 1.44 (s, 9H), 3.90 (br s, 2H), 4.81 (br s, 1H), 6.68 (d, 1H, J = 15.4 Hz), 6.89 (d, 1H, J = 15.4 Hz), 7.45-7.70 (m, 15H).

실시예Example 7: 3-옥소-5- 7: 3-oxo-5- 페닐Phenyl -2-(-2-( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 헥스Hex -4--4- 엔니트릴Ennitrile (3- (3- OxoOxo -5--5- phenyl phenyl -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )])] hexhex -4--4- enenitrileenenitrile ))

디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트 (224.0 mg, 0.47 mmol)을 함유한 무수 THF (15 mL)에 NaH (24.4 mg, 60% in oil, 1.3 당량)을 가하고, 아르곤 기체 속에서 상온에서 20분, 0 ℃에서 20분 동안 교반하여 연한 황갈색 용액을 수득하였다. 이 용액에 아세토페논 (54.6 mL, 1 당량)을 가하고 0 ℃에서 30분, 상온에서 24시간 동안 교반한 후, 물 (15 mL)을 가하여 반응을 정지시키고 생성물을 CH2Cl2 (20 mL)로 3회 추출하였다. 분리한 유기층을 전부 합하고 무수 마그네슘 설페이트 (5 g)을 가하여 수분을 제거한 다음 여과 후 농축하였다. 얻어진 잔류물을 크로마토그래피 (실리카겔 컬럼; 20 cm x 2 cm, Merck 70-230, 용매; CH2Cl2 : 에틸 아세테이트 = 20 : 1)로 분리하여 143.7 mg (69 %, E- / Z-이성질체 비율: ca. 4/6)의 표제 화합물을 수득하였다. NaH (24.4 mg, 60 in anhydrous THF (15 mL) containing diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate (224.0 mg, 0.47 mmol) % in oil, 1.3 equivalents) was added and stirred in argon gas at room temperature for 20 minutes and at 0 ° C. for 20 minutes to give a light tan solution. Acetophenone (54.6 mL, 1 equiv) was added to the solution, stirred at 0 ° C. for 30 minutes at room temperature for 24 hours, and then water (15 mL) was added to stop the reaction and the product was CH 2 Cl 2. Extracted with 3 times (20 mL). All the separated organic layers were combined, anhydrous magnesium sulfate (5 g) was added to remove water, and then filtered and concentrated. The residue obtained was separated by chromatography (silica gel column; 20 cm x 2 cm, Merck 70-230, solvent; CH 2 Cl 2 : ethyl acetate = 20: 1) to give 143.7 mg (69%, E- / Z -isomer Proportion: The title compound of ca. 4/6) was obtained.

E-이성질체: E -isomers:

1H NMR (CDCl3, 400 MHz) δ 2.45 (br d, 3H, J = 1.5 Hz), 7.04 (br d, 1H, J = 1.5 Hz), 7.28-7.72 (m, 20H). 1 H NMR (CDCl 3 , 400 MHz) δ 2.45 (br d, 3H, J = 1.5 Hz), 7.04 (br d, 1H, J = 1.5 Hz), 7.28-7.72 (m, 20H).

Z-이성질체: Z -isomers:

1H NMR (CDCl3, 400 MHz) δ 2.17 (br d, 3H, J = 1.0 Hz), 6.60 (br d, 1H, J = 1.0 Hz), 7.24-7.70 (m, 20H). 1 H NMR (CDCl 3 , 400 MHz) δ 2.17 (br d, 3H, J = 1.0 Hz), 6.60 (br d, 1H, J = 1.0 Hz), 7.24-7.70 (m, 20H).

실시예Example 8: 3-옥소-5,5- 8: 3-oxo-5,5- 디페닐Diphenyl -2-(-2-( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 펜트Pent -4--4- 엔니트릴Ennitrile (3- (3- OxoOxo -5,5--5,5- diphenyldiphenyl -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) pentpent -4--4- enenitrileenenitrile ))

디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트 (230.0 mg, 0.48 mmol)을 함유한 무수 THF (15 mL)에 NaH (25.0 mg, 60% in oil, 1.3 당량)을 가하고, 아르곤 기체 속에서 상온에서 20분, 0 ℃에서 20분 동안 교반하여 연한 황갈색 용액을 수득하였다. 이 용액에 벤조페논 (87.5 mg, 1 당량)를 가하고 0 ℃에서 30분, 상온에서 22시간 동안 교반한 후, 물 (15 mL)을 가하여 반응을 정지시키고 생성물을 CH2Cl2 (20 mL)로 3회 추출하였다. 분리한 유기층을 전부 합하고 무수 마그네슘 설페이트 (5 g)을 가하여 수분을 제거한 다음 여과 후 농축하였다. 얻어진 잔류물을 크로마토그래피 (실리카겔 컬럼; 20 cm x 2 cm, Merck 70-230, 용매; CH2Cl2 : 에틸 아세테이트 = 20 : 1)로 분리하여 141.4 mg (58 %)의 표제 화합물을 수득하였다. NaH (25.0 mg, 60 in anhydrous THF (15 mL) containing diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate (230.0 mg, 0.48 mmol) % in oil, 1.3 equivalents) was added and stirred in argon gas at room temperature for 20 minutes and at 0 ° C. for 20 minutes to give a light tan solution. To this solution, benzophenone (87.5 mg, 1 equiv) was added, stirred at 0 ° C. for 30 minutes at room temperature for 22 hours, and then water (15 mL) was added to stop the reaction and the product was CH 2 Cl 2. Extracted with 3 times (20 mL). All the separated organic layers were combined, anhydrous magnesium sulfate (5 g) was added to remove water, and then filtered and concentrated. The residue obtained was separated by chromatography (silica gel column; 20 cm x 2 cm, Merck 70-230, solvent; CH 2 Cl 2 : ethyl acetate = 20: 1) to give 141.4 mg (58%) of the title compound. .

1H NMR (CDCl3, 400 MHz) δ 7.04 (s, 1H), 7.28-7.62 (m, 25H). 1 H NMR (CDCl 3 , 400 MHz) δ 7.04 (s, 1H), 7.28-7.62 (m, 25H).

실시예Example 9: 3-옥소-5- 9: 3-oxo-5- 페닐Phenyl -2-(-2-( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 펜탄니트릴Pentanenitrile (3- (3- OxoOxo -5--5- phenylphenyl -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) pentanenitrilepentanenitrile ))

실시예 1에서 수득한 3-옥소-5-페닐-2-(트리페닐포스포라닐리덴)펜트-4-엔니트릴 (216.0 mg, 0.50 mmol)과 Pd-C (10%) (21.6 mg, 10 중량%)를 함유한 혼합용매 (5 mL, THF/MeOH, 1/1) 슬러리를 상온에서 1기압의 수소기체 속에서 3시간 동안 교 반하였다. 반응물을 여과하고 잔류물을 다시 15 mL의 THF 및 MeOH로 세척하고, 감압 하에서 용매를 제거한 후 진공 건조시켜 212.6 mg (98 %)의 흰색 고체인 표제 화합물을 수득하였다. 3-oxo-5-phenyl-2- (triphenylphosphoranylidene) pent-4-ennitrile (216.0 mg, 0.50 mmol) and Pd-C (10%) obtained in Example 1 (21.6 mg, 10 Mixed solvent (5 mL, THF / MeOH, 1/1) slurry was stirred at room temperature for 1 hour in a hydrogen gas at room temperature. The reaction was filtered and the residue was washed again with 15 mL of THF and MeOH, the solvent was removed under reduced pressure and then dried in vacuo to give 212.6 mg (98%) of the title compound as a white solid.

mp 172.0-174.0 ℃; IR (KBr) 2172, 1584 cm-1; 1H NMR (CDCl3, 400 MHz) δ 3.06 (t, 2H, J = 7.1 Hz), 3.16 (t, 2H, J = 7.1 Hz), 7.18-7.32 (m, 5H), 7.45-7.70 (m, 15H); 13C NMR (100 MHz, CDCl3) δ 31.2, 40.4 (d, J C -P = 7.4 Hz), 48.7 (d, J C -P = 126.6 Hz), 122.6 (d, J C -P = 16.6 Hz), 123.2 (d, J C -P = 93.5 Hz), 125.8, 128.2, 128.7, 129.1 (d, J C -P = 13.2 Hz), 133.0 (d, J C -P = 3.3 Hz), 133.5 (d, J C -P = 9.9 Hz), 141.5, 195.9 (d, J C -P = 3.3 Hz); HRMS calcd for C29H24NOP 433.1596, found 433.1596.mp 172.0-174.0 ° C; IR (KBr) 2172, 1584 cm −1 ; 1 H NMR (CDCl 3 , 400 MHz) δ 3.06 (t, 2H, J = 7.1 Hz), 3.16 (t, 2H, J = 7.1 Hz), 7.18-7.32 (m, 5H), 7.45-7.70 (m, 15H); 13 C NMR (100 MHz, CDCl 3 ) δ 31.2, 40.4 (d, J C -P = 7.4 Hz), 48.7 (d, J C -P = 126.6 Hz), 122.6 (d, J C -P = 16.6 Hz ), 123.2 (d, J C -P = 93.5 Hz), 125.8, 128.2, 128.7, 129.1 (d, J C -P = 13.2 Hz), 133.0 (d, J C -P = 3.3 Hz), 133.5 (d , J C -P = 9.9 Hz), 141.5, 195.9 (d, J C -P = 3.3 Hz); HRMS calcd for C 29 H 24 NOP 433.1596, found 433.1596.

실시예Example 10: 3-옥소-5- 10: 3-oxo-5- oo -- 톨릴Tolyl -2-(-2-( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 펜탄니트릴Pentanenitrile (3- (3- OxoOxo -5-o--5-o- tolyltolyl -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) pentanenitrilepentanenitrile ))

실시예 2에서 수득한 3-옥소-5-o-톨릴-2-(트리페닐포스포라닐리덴)펜트-4-엔니트릴 (148.0 mg, 0.33 mmol)과 Pd-C (10%) (14.8 mg, 10 중량%)를 함유한 혼합용매 (4 mL, THF/MeOH, 1/1) 슬러리를 상온에서 1기압의 수소기체 속에서 10 시간 동안 교반하였다. 반응물을 여과하고 잔류물을 다시 8 mL의 THF 및 MeOH로 세척하고, 용매를 감압 하에서 제거한 후 진공 건조시켜 144.0 mg (97 %)의 표제 화합물 을 수득하였다. 3-oxo-5- o -tolyl-2- (triphenylphosphoranilidene) pent-4-ennitrile (148.0 mg, 0.33 mmol) and Pd-C (10%) obtained in Example 2 (14.8 mg) , 10 wt%) mixed solvent (4 mL, THF / MeOH, 1/1) slurry was stirred for 10 hours in a hydrogen gas of 1 atm at room temperature. The reaction was filtered and the residue was washed again with 8 mL of THF and MeOH, the solvent was removed under reduced pressure and then dried in vacuo to give 144.0 mg (97%) of the title compound.

1H NMR (CDCl3, 400 MHz) δ 2.35 (s, 3H), 2.98 (br s, 4H), 7.10-7.25 (m, 4H), 7.47-7.73 (m, 15H). 1 H NMR (CDCl 3 , 400 MHz) δ 2.35 (s, 3H), 2.98 (br s, 4H), 7.10-7.25 (m, 4H), 7.47-7.73 (m, 15H).

실시예Example 11: 5-(2,6- 11: 5- (2,6- 디메틸페닐Dimethylphenyl )-3-옥소-2-() -3-oxo-2- ( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 펜탄니트릴Pentanenitrile (5-(2,6- (5- (2,6- DimethylphenylDimethylphenyl )-3-) -3- oxooxo -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) pentanenitrilepentanenitrile ))

실시예 3에서 수득한 5-(2,6-디메틸페닐)-3-옥소-2-(트리페닐포스포라닐리덴)펜트-4-엔니트릴 (105.0 mg, 0. 23 mmol)과 Pd-C (10%) (31.5 mg, 30 중량%)를 함유한 혼합용매 (4 mL, THF/MeOH, 1/1) 슬러리를 상온에서 1기압의 수소기체 속에서 24시간 동안 교반하였다. 반응물을 여과하고 잔류물을 다시 8 mL의 THF 및 MeOH로 세척하고, 용매를 감압 하에서 제거한 후 진공 건조시켜 100.2 mg (95 %)의 표제 화합물을 수득하였다.5- (2,6-dimethylphenyl) -3-oxo-2- (triphenylphosphoranylidene) pent-4-ennitrile (105.0 mg, 0.23 mmol) and Pd-C obtained in Example 3 A mixed solvent (4 mL, THF / MeOH, 1/1) slurry containing (10%) (31.5 mg, 30% by weight) was stirred for 24 hours at 1 atmosphere of hydrogen gas at room temperature. The reaction was filtered and the residue was washed again with 8 mL of THF and MeOH, the solvent was removed under reduced pressure and then dried in vacuo to yield 100.2 mg (95%) of the title compound.

1H NMR (CDCl3, 400 MHz) δ 2.37 (s, 6H), 2.83 (t, 2H, J = 8.3 Hz), 2.99 (t, 2H, J = 8.3 Hz), 7.00 (br s, 3H), 7.49-7.69 (m, 15H). 1 H NMR (CDCl 3 , 400 MHz) δ 2.37 (s, 6H), 2.83 (t, 2H, J = 8.3 Hz), 2.99 (t, 2H, J = 8.3 Hz), 7.00 (br s, 3H), 7.49-7.69 (m, 15 H).

실시예Example 12: 3-옥소-7- 12: 3-oxo-7- 페닐Phenyl -2-(-2-( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 헵탄니트릴Heptanenitrile (3- (3- OxoOxo -7--7- phenylphenyl -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) heptanenitrileheptanenitrile ))

실시예 4에서 수득한 3-옥소-7-페닐-2-(트리페닐포스포라닐리덴)헵트-4-엔니 트릴 (100.0 mg, 0.22 mmol)과 Pd-C (10%) (10.0 mg, 10 중량%)를 함유한 혼합용매 (4 mL, THF/MeOH, 1/1) 슬러리를 상온에서 1기압의 수소기체 속에서 3시간 동안 교반하였다. 반응물을 여과하고 잔류물을 다시 8 mL의 THF 및 MeOH로 세척하고, 용매를 감압 하에서 제거한 후 진공 건조시켜 98.5 mg (98 %)의 표제 화합물을 수득하였다. 3-oxo-7-phenyl-2- (triphenylphosphoranylidene) hept-4-ennitrile (100.0 mg, 0.22 mmol) and Pd-C (10%) (10.0 mg, 10 obtained in Example 4 A mixed solvent (4 mL, THF / MeOH, 1/1) slurry containing a wt%) was stirred for 3 hours at 1 atmosphere of hydrogen gas at room temperature. The reaction was filtered and the residue was washed again with 8 mL of THF and MeOH, the solvent was removed under reduced pressure and dried in vacuo to give 98.5 mg (98%) of the title compound.

1H NMR (CDCl3, 400 MHz) δ 1.63-1.83 (m, 4H), 2.64 (t, 2H, J = 7.6 Hz), 2.82 (t, 2H, J = 7.3 Hz), 7.13-7.32 (m, 5H), 7.48-7.70 (m, 15H). 1 H NMR (CDCl 3 , 400 MHz) δ 1.63-1.83 (m, 4H), 2.64 (t, 2H, J = 7.6 Hz), 2.82 (t, 2H, J = 7.3 Hz), 7.13-7.32 (m, 5H), 7.48-7.70 (m, 15H).

실시예Example 13: 3-옥소-2-( 13: 3-oxo-2- ( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 도데칸니트릴Dodecanenitrile (3- (3- OxoOxo -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) dodecanenitriledodecanenitrile ))

실시예 5에서 수득한 3-옥소-2-(트리페닐포스포라닐리덴)도데크-4-엔니트릴 (155.9 mg, 0.34 mmol)과 Pd-C (10%) (16.0 mg, 10 중량%)를 함유한 혼합용매 (4 mL, THF/MeOH, 1/1) 슬러리를 상온에서 1기압의 수소기체 속에서 3시간 동안 교반하였다. 반응물을 여과하고 잔류물을 다시 8 mL의 THF 및 MeOH로 세척하고, 용매를 감압 하에서 제거한 후 진공 건조시켜 152.0 mg (97 %)의 표제 화합물을 수득하였다. 3-oxo-2- (triphenylphosphoranylidene) dodec-4-enenitrile (155.9 mg, 0.34 mmol) and Pd-C (10%) (16.0 mg, 10% by weight) obtained in Example 5 Mixed solvent containing (4 mL, THF / MeOH, 1/1) slurry was stirred for 3 hours in a hydrogen gas of 1 atm at room temperature. The reaction was filtered and the residue was washed again with 8 mL of THF and MeOH, the solvent was removed under reduced pressure and dried in vacuo to afford 152.0 mg (97%) of the title compound.

1H NMR (CDCl3, 400 MHz) δ 0.88 (t, 3H, J = 6.8 Hz), 1.20-1.42 (m, 12H), 1.65-1.75 (m, 2H), 2.76 (t, 2H, J = 7.6 Hz), 7.49-7.71 (m, 15H). 1 H NMR (CDCl 3 , 400 MHz) δ 0.88 (t, 3H, J = 6.8 Hz), 1.20-1.42 (m, 12H), 1.65-1.75 (m, 2H), 2.76 (t, 2H, J = 7.6 Hz), 7.49-7.71 (m, 15 H).

실시예Example 14: [5- 14: [5- 시아노Cyano -4-옥소-5-(-4-oxo-5- ( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 펜틸Pentyl }} 카바믹Carbamic  mountain tt -부틸 에스테르 ([5--Butyl ester ([5- CyanoCyano -4--4- oxooxo -5-(-5- ( triphenylphosphoranylidenetriphenylphosphoranylidene )) pentylpentyl ]] carbamiccarbamic acidacid terttert -butyl -butyl esterester ))

실시예 6에서 수득한 [5-시아노-4-옥소-5-(트리페닐포스포라닐리덴)펜트-2-엔일]카바믹 산 t-부틸 에스테르 (178.0 mg, 0.37 mmol)와 Pd-C (10%) (17.8 mg, 10 중량%)를 함유한 혼합용매 (4 mL, THF/MeOH, 1/1) 슬러리를 상온에서 1기압의 수소기체 속에서 3시간 동안 교반하였다. 반응물을 여과하고 잔류물을 다시 8 mL의 THF 및 MeOH로 세척하고, 용매를 감압 하에서 제거한 후 진공 건조시켜 162.6 mg (91 %)의 표제 화합물을 수득하였다. [5-cyano-4-oxo-5- (triphenylphosphoranylidene) pent-2-enyl] carbamic acid t -butyl ester (178.0 mg, 0.37 mmol) and Pd-C obtained in Example 6 A mixed solvent (4 mL, THF / MeOH, 1/1) slurry containing (10%) (17.8 mg, 10% by weight) was stirred for 3 hours at 1 atmosphere in a hydrogen gas. The reaction was filtered and the residue was washed again with 8 mL of THF and MeOH, the solvent was removed under reduced pressure and dried in vacuo to yield 162.6 mg (91%) of the title compound.

1H NMR (CDCl3, 400 MHz) δ 1.43 (s, 9H), 1.78-1.88 (m, 2H), 2.74 (t, 2H, J = 7.3 Hz), 3.15 (br q, 2H), 4.77 (br s, 1H), 7.49-7.69 (m, 15H). 1 H NMR (CDCl 3 , 400 MHz) δ 1.43 (s, 9H), 1.78-1.88 (m, 2H), 2.74 (t, 2H, J = 7.3 Hz), 3.15 (br q, 2H), 4.77 (br s, 1 H), 7.49-7.69 (m, 15 H).

실시예Example 15: 3-옥소-5- 15: 3-oxo-5- 페닐Phenyl -2-(-2-( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 헥산니트릴Hexanenitrile (3- (3- OxoOxo -5--5- phenylphenyl -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) hexanenitrilehexanenitrile ))

실시예 7에서 수득한 3-옥소-5-페닐-2-(트리페닐포스포라닐리덴)헥스-4-엔니트릴 (116.0 mg, 0.26 mmol)과 Pd-C (10%) (34.8 mg, 30 중량%)를 함유한 혼합용매 (4 mL, THF/MeOH, 1/1) 슬러리를 상온에서 1기압의 수소기체 속에서 10시간 동안 교반하였다. 반응물을 여과하고 잔류물을 다시 8 mL의 THF 및 MeOH로 세척하고, 용매를 감압 하에서 제거한 후 진공 건조시켜 115.2 mg (99 %)의 표제 화합물을 수득하였다. 3-oxo-5-phenyl-2- (triphenylphosphoranylidene) hex-4-enenitrile (116.0 mg, 0.26 mmol) and Pd-C (10%) obtained in Example 7 (34.8 mg, 30 A mixed solvent (4 mL, THF / MeOH, 1/1) slurry containing a weight percent) was stirred for 10 hours in a hydrogen gas at 1 atmosphere at room temperature. The reaction was filtered and the residue was washed again with 8 mL of THF and MeOH, the solvent was removed under reduced pressure and dried in vacuo to afford 115.2 mg (99%) of the title compound.

1H NMR (CDCl3, 400 MHz) δ 1.29 (d, 3H, J = 6.8 Hz), 2.81 (dd, 1H, J 1 = 14.6 Hz, J 2 = 6.8 Hz), 3.21 (dd, 1H, J 1 = 14.6 Hz, J 2 = 8.8 Hz), 3.38-3.44 (m, 1H), 7.20-7.65 (m, 20H). 1 H NMR (CDCl 3 , 400 MHz) δ 1.29 (d, 3H, J = 6.8 Hz), 2.81 (dd, 1H, J 1 = 14.6 Hz, J 2 = 6.8 Hz), 3.21 (dd, 1H, J 1 = 14.6 Hz, J 2 = 8.8 Hz), 3.38-3.44 (m, 1H), 7.20-7.65 (m, 20H).

실시예Example 16: 3-옥소-5,5- 16: 3-oxo-5,5- 디페닐Diphenyl -2-(-2-( 트리페닐포스포라닐리덴Triphenylphosphoranylidene )) 펜탄니트릴Pentanenitrile (3- (3- OxoOxo -5,5--5,5- diphenyldiphenyl -2-(-2-( triphenylphosphoranylidenetriphenylphosphoranylidene )) pentanenitrilepentanenitrile ))

실시예 8에서 수득한 3-옥소-5,5-디페닐-2-(트리페닐포스포라닐리덴)펜트-4-엔니트릴 (125.0 mg, 0.25 mmol)과 Pd-C (10%) (37.5 mg, 30 중량%)를 함유한 혼합용매 (4 mL, THF/MeOH, 1/1) 슬러리를 상온에서 1기압의 수소기체 속에서 6시간 동안 교반하였다. 반응물을 여과하고 잔류물을 다시 8 mL의 THF 및 MeOH로 세척하고, 용매를 감압 하에서 제거한 후 진공 건조시켜 124.1 mg (99 %)의 표제 화합물을 수득하였다. 3-oxo-5,5-diphenyl-2- (triphenylphosphoranylidene) pent-4-ennitrile (125.0 mg, 0.25 mmol) and Pd-C (10%) obtained in Example 8 (37.5) mg, 30% by weight) mixed solvent (4 mL, THF / MeOH, 1/1) slurry was stirred for 6 hours in a hydrogen gas of 1 atm at room temperature. The reaction was filtered and the residue was washed again with 8 mL of THF and MeOH, the solvent was removed under reduced pressure and dried in vacuo to afford 124.1 mg (99%) of the title compound.

1H NMR (CDCl3, 400 MHz) δ 3.45 (d, 2H, J = 7.8 Hz), 4.70 (t, 1H, J = 7.8 Hz), 7.18-7.64 (m, 25H). 1 H NMR (CDCl 3 , 400 MHz) δ 3.45 (d, 2H, J = 7.8 Hz), 4.70 (t, 1H, J = 7.8 Hz), 7.18-7.64 (m, 25H).

Claims (11)

(i) 하기 화학식 I의 디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트를 하기 화학식 II의 카르보닐 화합물과 호르너-워스워스-에몬스 올레핀화 반응시켜 하기 화학식 III의 β,γ-불포화 α-케토 시아노포스포레인 화합물을 수득하는 단계; 및(i) diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate of formula (I) with Hornyl-Worthworth-Emons Olefining to obtain a β, γ-unsaturated α-keto cyanophosphorane compound of formula III; And (ii) 하기 화학식 III의 β,γ-불포화 α-케토 시아노포스포레인 화합물을 촉매 수소화 반응을 시키는 단계를 포함하는 하기 화학식 IV의 β,γ-포화 α-케토 시아노포스포레인 화합물의 제조방법: (ii) a process for preparing the β, γ-saturated α-keto cyanophosphorane compound of formula (IV) comprising the step of subjecting the β, γ-unsaturated α-keto cyanophosphorane compound of formula (III) to a catalytic hydrogenation reaction : [화학식 I][Formula I]
Figure 112009038226554-pat00008
Figure 112009038226554-pat00008
[화학식 II][Formula II]
Figure 112009038226554-pat00009
Figure 112009038226554-pat00009
[화학식 III][Formula III]
Figure 112009038226554-pat00010
Figure 112009038226554-pat00010
[화학식 IV][Formula IV]
Figure 112009038226554-pat00011
Figure 112009038226554-pat00011
상기 식에서, R1 및 R2는 각각 독립적으로 수소; 페닐기 또는 보호되거나 비보호된 아미노기에 의해 치환되거나 비치환된 C1-C15의 알킬기; 또는 하나 이상의 C1-C5의 알킬기에 의해 치환되거나 비치환된 아릴기이다.In the above formula, R 1 and R 2 are each independently hydrogen; C 1 -C 15 alkyl groups unsubstituted or substituted by a phenyl group or a protected or unprotected amino group; Or an aryl group unsubstituted or substituted by one or more C 1 -C 5 alkyl groups.
제1항에 있어서, R1 및 R2가 각각 독립적으로 수소; 페닐기 또는 보호되거나 비보호된 아미노기에 의해 치환되거나 비치환된 C1-C15의 알킬기; 또는 하나 이상의 C1-C5의 알킬기에 의해 치환되거나 비치환된 페닐기인 것을 특징으로 하는 제조방법.The compound of claim 1, wherein R 1 and R 2 are each independently hydrogen; C 1 -C 15 alkyl groups unsubstituted or substituted by a phenyl group or a protected or unprotected amino group; Or a phenyl group unsubstituted or substituted by one or more C 1 -C 5 alkyl groups. 제1항에 있어서, R1 및 R2가 각각 독립적으로 수소; 메틸, 에틸, 프로필, 부틸, 펜틸, 헥실, 헵틸, 옥틸, 벤질, 2-페닐에틸, 아미노메틸 및 t-부틸옥시카보닐아미노메틸로 구성된 군으로부터 선택된 알킬기; 또는 페닐, 2-메틸페닐, 3-메틸페닐, 4-메틸페닐, 2,4-디메틸페닐 및 2,6-디메틸페닐로 구성된 군으로부터 선택된 아릴기인 것을 특징으로 하는 제조방법.The compound of claim 1, wherein R 1 and R 2 are each independently hydrogen; An alkyl group selected from the group consisting of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, benzyl, 2-phenylethyl, aminomethyl and t-butyloxycarbonylaminomethyl; Or an aryl group selected from the group consisting of phenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 2,4-dimethylphenyl and 2,6-dimethylphenyl. 제1항에 있어서, 단계 (i)에서 호르너-워스워스-에몬스 올레핀화 반응이 염 기의 존재 하에 수행되는 것을 특징으로 하는 제조방법.The process according to claim 1, wherein in step (i) the Horner-Worthworth-Emonth olefination reaction is carried out in the presence of a base group. 제4항에 있어서, 염기가 수소화나트륨 (NaH)인 것을 특징으로 하는 제조방법.5. A process according to claim 4 wherein the base is sodium hydride (NaH). 제1항에 있어서, 단계 (ii)에서 수소화 반응이 팔라듐 촉매 (Pd-C)의 존재 하에 수소 기체를 이용하여 수행되는 것을 특징으로 하는 제조방법.The process according to claim 1, wherein the hydrogenation reaction in step (ii) is carried out using hydrogen gas in the presence of a palladium catalyst (Pd-C). 하기 화학식 I의 디에틸 [3-시아노-2-옥소-3-(트리페닐포스포라닐리덴)프로필]포스포네이트를 하기 화학식 II의 카르보닐 화합물과 호르너-워스워스-에몬스 올레핀화 반응시키는 것을 특징으로 하는 하기 화학식 III의 β,γ-불포화 α-케토 시아노포스포레인 화합물의 제조방법: The diethyl [3-cyano-2-oxo-3- (triphenylphosphoranylidene) propyl] phosphonate of formula (I) is reacted with a carbonyl compound of formula (II) with Horner-Worthworth-Emons olefination Method for preparing a β, γ-unsaturated α-keto cyanophosphorane compound of formula III: [화학식 I][Formula I]
Figure 112009038226554-pat00012
Figure 112009038226554-pat00012
[화학식 II][Formula II]
Figure 112009038226554-pat00013
Figure 112009038226554-pat00013
[화학식 III][Formula III]
Figure 112009038226554-pat00014
Figure 112009038226554-pat00014
상기 식에서, R1 및 R2는 각각 독립적으로 수소; 페닐기 또는 보호되거나 비보호된 아미노기에 의해 치환되거나 비치환된 C1-C15의 알킬기; 또는 하나 이상의 C1-C5의 알킬기에 의해 치환되거나 비치환된 아릴기이다.In the above formula, R 1 and R 2 are each independently hydrogen; C 1 -C 15 alkyl groups unsubstituted or substituted by a phenyl group or a protected or unprotected amino group; Or an aryl group unsubstituted or substituted by one or more C 1 -C 5 alkyl groups.
제7항에 있어서, R1 및 R2가 각각 독립적으로 수소; 페닐기 또는 보호되거나 비보호된 아미노기에 의해 치환되거나 비치환된 C1-C15의 알킬기; 또는 하나 이상의 C1-C5의 알킬기에 의해 치환되거나 비치환된 페닐기인 것을 특징으로 하는 제조방법.The compound of claim 7, wherein R 1 and R 2 are each independently hydrogen; C 1 -C 15 alkyl groups unsubstituted or substituted by a phenyl group or a protected or unprotected amino group; Or a phenyl group unsubstituted or substituted by one or more C 1 -C 5 alkyl groups. 제7항에 있어서, R1 및 R2가 각각 독립적으로 수소; 메틸, 에틸, 프로필, 부틸, 펜틸, 헥실, 헵틸, 옥틸, 벤질, 2-페닐에틸, 아미노메틸 및 t-부틸옥시카보닐아미노메틸로 구성된 군으로부터 선택된 알킬기; 또는 페닐, 2-메틸페닐, 3-메틸페닐, 4-메틸페닐, 2,4-디메틸페닐 및 2,6-디메틸페닐로 구성된 군으로부터 선택된 아릴기인 것을 특징으로 하는 제조방법.The compound of claim 7, wherein R 1 and R 2 are each independently hydrogen; An alkyl group selected from the group consisting of methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, benzyl, 2-phenylethyl, aminomethyl and t-butyloxycarbonylaminomethyl; Or an aryl group selected from the group consisting of phenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 2,4-dimethylphenyl and 2,6-dimethylphenyl. 제7항에 있어서, 호르너-워스워스-에몬스 올레핀화 반응이 염기의 존재하에 수행되는 것을 특징으로 하는 제조방법.8. A process according to claim 7, wherein the Horner-Worthworth-Emons olefination reaction is carried out in the presence of a base. 제10항에 있어서, 염기가 수소화나트륨(NaH)인 것을 특징으로 하는 제조방법.The process according to claim 10, wherein the base is sodium hydride (NaH).
KR1020080030201A 2008-04-01 2008-04-01 PROCESS OF PREPARING alpha;-KETO CYANOPHOSPHORANES FROM CARBONYL COMPOUNDS KR100911357B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020080030201A KR100911357B1 (en) 2008-04-01 2008-04-01 PROCESS OF PREPARING alpha;-KETO CYANOPHOSPHORANES FROM CARBONYL COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080030201A KR100911357B1 (en) 2008-04-01 2008-04-01 PROCESS OF PREPARING alpha;-KETO CYANOPHOSPHORANES FROM CARBONYL COMPOUNDS

Publications (1)

Publication Number Publication Date
KR100911357B1 true KR100911357B1 (en) 2009-08-07

Family

ID=41209610

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080030201A KR100911357B1 (en) 2008-04-01 2008-04-01 PROCESS OF PREPARING alpha;-KETO CYANOPHOSPHORANES FROM CARBONYL COMPOUNDS

Country Status (1)

Country Link
KR (1) KR100911357B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100994548B1 (en) 2008-04-01 2010-11-15 우석대학교 산학협력단 Diethyl [3-cyano-2-oxo-3-triphenylphosphoranylidenepropyl]phosphonate and process of preparing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
해당사항 없음

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100994548B1 (en) 2008-04-01 2010-11-15 우석대학교 산학협력단 Diethyl [3-cyano-2-oxo-3-triphenylphosphoranylidenepropyl]phosphonate and process of preparing the same

Similar Documents

Publication Publication Date Title
MXPA02007307A (en) Asymmetric synthesis of pregabalin.
EP2134673A1 (en) Improved process for preparing o-chloromethylphenylglyoxylic esters, improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters, and novel intermediates for their preparation
HRP20040935A2 (en) Method for preparing combretastatins
KR101726116B1 (en) Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide
KR100911357B1 (en) PROCESS OF PREPARING alpha;-KETO CYANOPHOSPHORANES FROM CARBONYL COMPOUNDS
CN108948077B (en) Alpha-phosphorylated alpha-amino acid ester compound and synthesis method thereof
JPH02306947A (en) Preparation of chiral bata-amino acid
JP2002501531A (en) Method for producing substituted keto-enamines
KR100994548B1 (en) Diethyl [3-cyano-2-oxo-3-triphenylphosphoranylidenepropyl]phosphonate and process of preparing the same
JP5448572B2 (en) Acetyl compound, method for producing the acetyl compound, and method for producing a naphthol compound using the acetyl compound
KR101885084B1 (en) Novel amidation of N-acyl indole derivatives
JP2003300988A (en) Method for producing optically active secondary phosphineborane derivative and its intermediate
US6271378B1 (en) Process for preparing tricyclic compounds having antihistaminic activity
KR102500285B1 (en) Amine boron cluster compound and method preparating the same
KR101085202B1 (en) Process of preparing ?-keto cyanomethylenetriphenylphosphoranes from alkyl bromides
KR100576740B1 (en) Sphingosine precursor, its synthetic method, and sythetic method for sphingosine derivative using the precursor
KR101621754B1 (en) PROCESS OF PREPARING α-KETO (CYANOMETHYLENE)TRIPHENYLPHOSPHORANES USING XANTHATE COMPOUNDS
US20040225146A1 (en) Tyrosine phosphatase scafold synthesis
JP4379970B2 (en) Production method of olefin compounds
JP2008505860A (en) A method for producing an enantiomer of a 2,3-diaminopropionic acid derivative.
KR100252462B1 (en) Process for prparing o-(chloromethyl)benzoic acid ester derivatives
US5559268A (en) Process for the efficient preparation of N-substituted dehydroamino acid esters
KR101228381B1 (en) Preparation method of 5-membered ring compound
CN116675629A (en) Chiral dicarboxylic acid tetradentate binuclear rhodium catalyst based on natural amino acid, synthesis method and application thereof
WO2020010587A1 (en) β-PHOSPHONYL-ENAMINE DERIVATIVE AND PREPARATION METHOD THEREFOR

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee